Detalhe da pesquisa
1.
2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice.
Ann Rheum Dis
; 82(6): 754-762, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36858821
2.
Serum IFNα2 levels are associated with disease activity and outperform IFN-I gene signature in a longitudinal childhood-onset SLE cohort.
Rheumatology (Oxford)
; 62(8): 2872-2879, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515466
3.
Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
Rheumatology (Oxford)
; 61(5): 2156-2166, 2022 05 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34505866
4.
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study.
Rheumatology (Oxford)
; 61(11): 4344-4354, 2022 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35143620
5.
Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Rheumatology (Oxford)
; 61(8): 3491-3496, 2022 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35022662
6.
Innate immunity and interferons in the pathogenesis of Sjögren's syndrome.
Rheumatology (Oxford)
; 60(6): 2561-2573, 2021 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30770713
7.
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquine.
Rheumatol Int
; 41(9): 1593-1600, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34165604
8.
Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial.
Rheumatology (Oxford)
; 59(1): 107-111, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237947
9.
Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
Rheumatol Int
; 39(9): 1575-1584, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31139950
10.
TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
J Autoimmun
; 91: 97-102, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29673738
11.
Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
Rheumatology (Oxford)
; 57(5): 921-930, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29474655
12.
Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Ann Rheum Dis
; 76(4): 721-730, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-27672125
13.
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis.
Ann Rheum Dis
; 75(8): 1567-73, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26371289
14.
Bone Mineral Density in Sjögren Syndrome Patients with and Without Distal Renal Tubular Acidosis.
Calcif Tissue Int
; 98(6): 573-9, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-26873478
15.
Exaggerated Increases in Microglia Proliferation, Brain Inflammatory Response and Sickness Behaviour upon Lipopolysaccharide Stimulation in Non-Obese Diabetic Mice.
Neuroimmunomodulation
; 23(3): 137-150, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27529430
16.
Prevalence of distal renal tubular acidosis in primary Sjögren's syndrome.
Rheumatology (Oxford)
; 54(5): 933-9, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25354755
17.
MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
Ann Rheum Dis
; 73(6): 1052-9, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23831963
18.
MxA is a clinically applicable biomarker for type I interferon activation in systemic lupus erythematosus and systemic sclerosis.
Rheumatology (Oxford)
; 58(7): 1302-1303, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30879072
19.
Abnormalities of dendritic cell precursors in the pancreas of the NOD mouse model of diabetes.
Eur J Immunol
; 42(1): 186-94, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22002898
20.
Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Ann Rheum Dis
; 72(5): 728-35, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22736090